Autologous Mesenchymal Stroma Cells Are Superior to Allogeneic Ones in Bone Defect Regeneration

Autologous Mesenchymal Stroma Cells Are Superior to Allogeneic Ones in Bone Defect Regeneration

The application of autologous mesenchymal stem cells (MSC) for the treatment of bone defects requires two invasive procedures and several weeks of ex vivo cell expansion. To overcome these limitations, the administration of allogeneic MSC may be attractive, because they are anticipated to be immunop...

Full description

Bibliographic Details
Main Authors: Anna E. Rapp, Ronny Bindl, Annika Erbacher, Anne Kruchen, Markus Rojewski, Hubert Schrezenmeier, Ingo Müller, Anita Ignatius
Format: Article
Language:English
Published: MDPI AG 2018-08-01
Series:International Journal of Molecular Sciences
Subjects:
bone regeneration
large bone defect
humanized mouse
allogeneic
stem cells
MSC
Online Access:http://www.mdpi.com/1422-0067/19/9/2526

Internet

http://www.mdpi.com/1422-0067/19/9/2526

Similar Items